Leen H Kawas

This inventor holds 8 USPTO granted patents and 9 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Washington State University, Athira Pharma, Inc.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leen H Kawas. Retrieved from https://idiyas.com/inventor/leen-h-kawas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 9)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 4.6

ph-index = 2

Forward Citations = 17(Granted Patents)

Location History:

Pullman, WA (US) (2013 - 2015)
Seattle, WA (US) (2016 - 2021)
Lynnwood, WA (US) (2024)

Company Filing History:

5 out of 471

Washington State University

Years Active: 2013-2025

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12421276 - Methods of treating neurodegenerative disease with substituted n-hexanoic-l-tyrosine-l-isoleucine-(6)-aminohexanoic amide analogues (2025-09-23),

2. 11998556 - Methods of treating parkinson's disease and/or lewy body disease or disorder(s) (2024-06-04),

3. 11021514 - Compounds (2021-06-01),

4. 9475854 - Lead compound for otoprotection: targeting HGF signaling with dihexa (2016-10-25),

5. 9150613 - Hepatocyte growth factor mimics as therapeutic agents (2015-10-06),

6. 9066901 - C-Met receptor regulation by angiotensin IV (AT4) receptor ligands (2015-06-30),

7. 9051351 - Hepatocyte growth factor mimics as therapeutic agents (2015-06-09),

8. 8598118 - Hepatocyte growth factor mimics as therapeutic agents (2013-12-03),

Title: Leen H Kawas: Innovator in Neurodegenerative Disease Treatments

Introduction

Leen H Kawas is a prominent inventor based in Pullman, WA, with a strong focus on innovative treatments for neurodegenerative diseases. With a total of seven patents to her name, Kawas has made significant contributions to the understanding and treatment of conditions such as Parkinson's Disease and Alzheimer's.

Latest Patents

Among her latest patents, two stand out in particular. The first patent describes methods for treating Parkinson's Disease and/or Lewy body disease or disorders. This groundbreaking method involves the administration of a compound known as ATH-1017 to subjects. The second patent encompasses a range of compounds and methods useful in treating numerous pathologies, including Alzheimer's disease, amyotrophic lateral sclerosis, and various other neurodegenerative diseases. These innovations pave the way for improved therapeutic strategies in the medical field.

Career Highlights

Kawas has enjoyed an impactful career, notably working at Washington State University and Athira Pharma, Inc. Her work in these institutions has focused on advancing the understanding of neurodegenerative conditions and developing practical solutions to help those affected by these debilitating diseases.

Collaborations

Throughout her career, Kawas has collaborated with respected colleagues such as Joseph W Harding and John W Wright. These collaborations have enabled the exchange of valuable insights and have driven her innovative research forward.

Conclusion

Leen H Kawas exemplifies the spirit of innovation in the realm of medical science, especially concerning neurodegenerative diseases. Her patents and collaborations underline her commitment to improving patient outcomes and advancing therapeutic methods. Her contributions continue to inspire new research and development in the field, emphasizing the vital role of inventors in healthcare advancements.

Profile summary based on public USPTO records.